Sign Out
Each vial of 50 ml contains 2.5 g idarucizumab.
Idarucizumab solution for injection/infusion 50 mg/mL is a solution provided at a concentration of 50 mg/mL in a buffered, isotonic, preservative-free solution. The formulation is composed of 25 mM sodium acetate/acetate, 220 mM sorbitol and 0.2 g/L (0.02 w%) polysorbate 20 at pH 5.5. The container closure system consists of a Type 1 glass vial with a butyl rubber stopper, an aluminum cap and a label with integrated hanger.
Excipients/Inactive Ingredients: Acetic acid glacial, polysorbate 20, sodium acetate trihydrate, sorbitol, water for injection.
